CSat Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $15K | Buy |
69
+24
| +53% | +$5.22K | 0.01% | 412 |
|
|
2020
Q4 | $11K | Sell |
45
-1,428
| -97% | -$349K | 0.01% | 421 |
|
|
2020
Q3 | $401K | Buy |
1,473
+163
| +12% | +$44.4K | 0.04% | 191 |
|
|
2020
Q2 | $380K | Sell |
1,310
-512
| -28% | -$149K | 0.05% | 208 |
|
|
2020
Q1 | $434K | Buy |
1,822
+489
| +37% | +$116K | 0.09% | 156 |
|
|
2019
Q4 | $292K | Sell |
1,333
-424
| -24% | -$92.9K | 0.08% | 198 |
|
|
2019
Q3 | $298K | Buy |
1,757
+240
| +16% | +$40.7K | 0.09% | 176 |
|
|
2019
Q2 | $278K | Buy |
1,517
+1,481
| +4,114% | +$271K | 0.1% | 165 |
|
|
2019
Q1 | $7K | Buy |
36
+2
| +6% | +$389 | ﹤0.01% | 479 |
|
|
2018
Q4 | $6K | Buy |
34
+9
| +36% | +$1.59K | ﹤0.01% | 476 |
|
|
2018
Q3 | $5K | Sell |
25
-5
| -17% | -$1K | ﹤0.01% | 473 |
|
|
2018
Q2 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 465 |
|